Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |